{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-255041","form_type":"8-K","ticker":"MPLT","cik":"0001770069","company_name":"MapLight Therapeutics, Inc.","filed_at":"2025-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.372202+00:00","generated_at":"2026-05-17T01:41:54.875714+00:00","sec_items":["3.02","8.01","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"MapLight Therapeutics prices IPO at $17/sh, raises $296.3M including concurrent private placement","bullets":["IPO of 14.75M shares at $17.00; underwriters fully exercise option for 2.2125M additional shares.","Concurrent private placement to Goldman Sachs affiliates of 467,707 shares at same $17 price.","Total gross proceeds of $296.3M before underwriting discounts, placement agent fees, and expenses.","Amended and restated certificate of incorporation and bylaws effective upon IPO closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-255041","json":"https://secwatch.observer/filing/0001193125-25-255041.json","markdown":"https://secwatch.observer/filing/0001193125-25-255041.md","text":"https://secwatch.observer/filing/0001193125-25-255041.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1770069/000119312525255041/0001193125-25-255041-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1770069/000119312525255041/d89036d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:41:54.875714+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"01d1a9af2cdf3ce347f91abf5b4be747605390a9","claim":"MapLight Therapeutics, Inc.: Amended and restated certificate of incorporation filed in connection with IPO closing (effective 2025-10-28).","evidence_excerpt":"In connection with the closing of the initial public offering (“ IPO ”) of shares of common stock, par value $0.0001 per share (“ Common Stock ”), of MapLight Therapeutics, Inc. (the “ Company ”), on October 28, 2025, the Company filed an amended and restated certificate of incorporation (the “ Restated Certificate ”) with the Secretary of State of the State of Delaware.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1770069/000119312525255041/0001193125-25-255041-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-10-28"}],"fact_type":"governance_change"},{"claim_id":"deec7cdc7ac3cbef71f63c5842889a86811e2bc8","claim":"MapLight Therapeutics, Inc.: Amended and restated bylaws adopted effective upon IPO closing (effective 2025-10-28).","evidence_excerpt":"Effective as of October 28, 2025, the Company adopted amended and restated bylaws (the “ Restated Bylaws ”) in connection with the closing of the IPO.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1770069/000119312525255041/0001193125-25-255041-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2025-10-28"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}